This HTML5 document contains 166 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1182/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36835126
rdf:type
wikibase:Item
schema:description
scienca artikolo articolo scientifico article scientifique სამეცნიერო სტატია 2008年论文 2008年論文 article científic artigo científico artículo científico publicado en 2008 научная статья naučni članak ২৩ মে ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак บทความทางวิทยาศาสตร์ scientific article published on 23 May 2008 2008年论文 vetenskaplig artikel artículu científicu espublizáu en 2008 artikulong pang-agham 2008年論文 artikel ilmiah مقالة علمية نشرت في 23 مايو 2008 videnskabelig artikel научни чланак teaduslik artikkel vědecký článek 2008년 논문 bài báo khoa học 2008年論文 2008年論文 artigo científico מאמר מדעי bilimsel makale 2008年论文 мақолаи илмӣ научна статия 2008 nî lūn-bûn tudományos cikk articol științific scientific article published on 23 May 2008 2008年论文 επιστημονικό άρθρο artykuł naukowy vedecký článok artikull shkencor vitenskapelig artikkel 2008年论文 wissenschaftlicher Artikel 2008年の論文 wetenschappelijk artikel наукова стаття, опублікована в травні 2008 2008年论文 artigo científico article scientific tieteellinen artikkeli scientific article published on 23 May 2008 vitskapeleg artikkel 2008年論文
p:P577
wds:Q36835126-6D8E1E59-864A-4C22-A24F-D7C3E7D6C0E7
wdt:P577
2008-05-23T00:00:00Z
p:P407
wds:Q36835126-52B4572E-06D6-4228-87A2-D904544D072C
wdt:P407
wd:Q1860
p:P2860
wds:Q36835126-5BD97411-014A-4676-A881-582BA55E4A35 wds:Q36835126-5EB41F6F-69C4-4514-9DAA-134B3D86D0E1 wds:Q36835126-6F76A3FD-B56B-4CEB-972B-A494C6E10A79 wds:Q36835126-7647AD24-93F4-4D9C-9559-3D16FDF41766 wds:Q36835126-2BF9C09D-AFB7-4F51-AF5D-61D0DD096247 wds:Q36835126-42C77B39-61FA-410C-BFD5-58E8FCE02408 wds:Q36835126-4B2CF8F6-BFB2-4EE6-AE51-CD9868C42CC0 wds:Q36835126-04C0E2BA-3BDD-4E38-B25B-4BF6F41F1FEA wds:Q36835126-14F3BA17-96BE-48FB-A0CB-A2A67FDAFA7F wds:Q36835126-CD4EFB3F-2090-4D75-85F4-A828FCBBDA17 wds:Q36835126-E360ADE4-58CD-4F83-B53D-B6EC4A8EF090 wds:Q36835126-E730E1B7-9741-4561-B261-0B49868C6A69 wds:Q36835126-ED43369F-3A76-4AA9-99E2-A7CEFA456444 wds:Q36835126-B2E5ECED-DB55-408C-9343-8AA7D0242124 wds:Q36835126-B41DD5E9-D8DD-4AF8-8EC3-A6BD2E6EE2F2 wds:Q36835126-C5D2F04B-C8C1-4C4B-ABA7-543BFE273908 wds:Q36835126-C64A4BC7-FEE7-4893-8D3D-D7EF0BC9DA6B wds:Q36835126-CD1D8C1E-2675-4889-A6CD-19CE1D48D6AF wds:Q36835126-78075FF9-C376-4169-89A0-AE5DA9456474 wds:Q36835126-91AAC5D5-92C7-4894-BDFA-1523FFAE632A wds:Q36835126-950CE459-6277-456B-BFC7-B4CCF7EC6418 wds:Q36835126-A0FEA36F-7916-444E-A94F-8D3B2F3A5CF4
wdt:P2860
wd:Q36615576 wd:Q73911391 wd:Q33793177 wd:Q70582290 wd:Q70138444 wd:Q34326698 wd:Q68195420 wd:Q73894705 wd:Q37388077 wd:Q74576875 wd:Q47804385 wd:Q35607602 wd:Q41592255 wd:Q47606634 wd:Q49167492 wd:Q72258978 wd:Q72372127 wd:Q68928908 wd:Q73437152 wd:Q38091044 wd:Q33940061 wd:Q66829418
p:P2093
wds:Q36835126-BB85BAE8-5355-48B2-B0AF-6A563E72D85E wds:Q36835126-A7B8C26C-B0DF-4897-8BD9-3F57C412B2BF wds:Q36835126-AC52160B-A494-444D-B228-924423A6E337 wds:Q36835126-FF53AF86-D400-429B-A7BD-BC18F92D0BB3 wds:Q36835126-DB80A65C-503E-44F2-A577-DF9FDC8927C4 wds:Q36835126-0015C348-97ED-4943-904D-5867569FAFD4 wds:Q36835126-4C74069F-B4B1-4CC3-A10D-CC8FA1E07027
wdt:P2093
Thomas Braun Sung W Choi Kenneth Cooke Raymond J Hutchinson Dawn Jones Carrie L Kitko James L M Ferrara
rdfs:label
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.
skos:prefLabel
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.
schema:name
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.
p:P50
wds:Q36835126-CAA59F22-F155-4BC0-8D8B-4A03563267D8 wds:Q36835126-C3E5D571-2D28-4D48-B7B6-9631894718BA wds:Q36835126-CFD35DC9-15BB-49B8-90C5-8F767487C1AA wds:Q36835126-FCF2BDF9-D7CF-4AD9-B354-916444EADA40 wds:Q36835126-87A67CCF-8F5D-4538-9642-39B2F83C8404 wds:Q36835126-778A8B78-FEBF-4955-82F6-F5DFD3F2D0E1
wdt:P50
wd:Q116998092 wd:Q91453181 wd:Q116998090 wd:Q116998091 wd:Q56956100 wd:Q56479795
p:P1476
wds:Q36835126-F5B3EF89-152F-492A-ADCB-4420B135B0E9
wdt:P1476
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival
p:P304
wds:Q36835126-0F497113-1085-4043-AF30-2DE0C9D786C0
wdt:P304
1539-1542
p:P31
wds:Q36835126-3AAF9364-2DE7-460C-9370-11E1CB46363E
wdt:P31
wd:Q13442814
p:P698
wds:Q36835126-16323B7B-9948-4228-91B8-01F01FF282E8
wdtn:P698
n11:18502834
wdt:P698
18502834
p:P1433
wds:Q36835126-63462E21-9760-4EAC-8F32-6487D1FE334C
wdt:P1433
wd:Q885070
p:P433
wds:Q36835126-E5E13FCA-5077-4BCD-9364-47318CC24ECA
p:P478
wds:Q36835126-5AF18181-9349-4222-8232-D3E401475947
wdt:P433
4
wdt:P478
112
p:P1104
wds:Q36835126-484F67FE-474E-4970-9DF6-536E6D3F3647
wdt:P1104
4
p:P356
wds:Q36835126-1F03DB95-3517-4E64-9F73-A95445F03BDC
wdtn:P356
n10:BLOOD-2008-02-138867
wdt:P356
10.1182/BLOOD-2008-02-138867
p:P5875
wds:Q36835126-E823C671-A18A-4742-8154-9213B9490167
wdt:P5875
5347128
p:P932
wds:Q36835126-920B869F-2A8E-4462-A88E-AD92DB22BBC1
wdt:P932
2515125